Microorganisms P. radicum FKI-3765-2, previously reported as a xanthoradone-producing fungus, 13, 14) was used for production of 1. The following seven microorganisms were used for antimicrobial tests: Bacillus subtilis ATCC 6633, Staphylococcus aureus FDA 209P, Micrococcus luteus PCI 1001, Escherichia coli NIHJ, Xanthomonas campestris pv. Oryzae KB 88, Mucor racemosus IFO 4581 and C. albicans KF-1.
Regular Article
Opportunistic infections caused by certain fungi, in particular Candida albicans, have increased to the point of public concern. Patients with compromised immune systems, e.g., patients receiving organ transplants, cancer chemotherapy or those infected by human immunodeficiency virus, are particularly prone to such infections. 1) Recently, resistance to azole antifungals has become a significant problem. Several mechanisms of resistance have been proposed, including 1) overexpression of transporters, such as ATP binding cassette (ABC) transporter, 2) 2) mutation of cytochrome P-450 14-a demethylase (P-450 14DM), 3) and 3) overexpression of P450 14DM.
4) The mechanisms of resistance will indicate new targets of inhibition for overcoming infections by azole-resistant C. albicans. On the basis of the new concept of "antiinfective drugs," 5) we have screened microbial metabolites for potentiators of miconazole activity against C. albicans. As a result, we discovered various new compounds: actofunicone, 6) beauvericins, 7) citridones, 8, 9) tensidoles 10) and citrinamides 11) from fungi and phenatic acids 12) from an actinomycete. From precise analysis of the metabolites of xanthoradone-producing Penicillium radicum FKI-3765-2, 13) a new compound, designated 6Ј-hydroxy-3Ј-methoxy-mitorubrin (1, Fig. 1 ), with a core structure different from that of xanthoradones 14) was isolated along with known 4Ј-hydroxy-3Ј-methoxy-(S)-mitorubrin 15) (2) and monomethyl-(S)-mitorubrin 16) (3) . In this study, fermentation, isolation, and structural elucidation, including the absolute stereochemistry and miconazole-potentiating activity, of 1 are described.
fractions from the 3rd to 5th tube of 50% CH 3 CN containing 1 to 3 were concentrated in vacuo to dryness to give red brown material (120.8 mg). This material was finally purified by preparative HPLC (column, PEGASIL ODS, 20ϫ250 mm; Senshu Scientific Co.; solvent, 35% CH 3 CN containing 0.050% TFA; detection, UV at 210 nm; flow rate, 8.0 ml/min). Under these conditions, 1 to 3 were eluted as peaks with retention times of 52.9, 62.5 and 70.4 min, respectively. The fractions were concentrated in vacuo to dryness to give pure 1 (5.2 mg), 2 (1.8 mg) and 3 (2.5 mg) as yellow material.
Assay for Miconazole-Potentiating Activity C. albicans ATCC64548 was inoculated into a 50-ml test tube containing 10 ml seed medium (potato extract containing 0.50% peptone and 1.0% glucose), and was grown for 24 h on a rotary shaker. The assay for potentiating miconazole activity against C. albicans in combination with a sample was carried out by paper disk methods. 6) Briefly, the seed culture of C. albicans (0.10%, v/v) was transferred to two different agar plates, GY agar (1.0% glucose, 0.50% yeast extract and 0.80% agar, Plate A) and GY agar containing 0.060 mM miconazole (Plate B). The concentration (0.060 mM) of miconzole had no effect on the growth of C. albicans. Paper disks (6 mm i.d.; Toyo Roshi Kaisha Ltd., Tokyo, Japan) containing various concentrations of a sample were placed on Plates A and B, and incubated at 37°C for 24 h. A sample which showed an inhibition zone on Plate B and no inhibition on Plate A was selected as a potentiator of miconazole activity against C. albicans.
Antimicrobial Assays Antimicrobial activity against 6 species of microorganisms was measured by the paper disk method. Media for microorganisms were as follows: Nutrient agar (Sanko Junyaku Co., Ltd., Tokyo, Japan) for the bacteria; a medium composed of 1.0% glucose, 0.50% yeast extract and 0.80% agar for fungi and yeasts. A paper disk containing a sample (10 mg) was placed on an agar plate. Bacteria except X. oryzae were incubated at 37°C for 24 h. Yeasts and X. oryzae were incubated at 27°C for 24 h. Antimicrobial activity of a sample was expressed as the diameter (mm) of the inhibitory zone.
Results and Discussion
Physico-Chemical Properties The physico-chemical properties of 1 are summarized in Table 1 . This compound had absorption maxima at 250 nm and 347 nm on UV spectra. The IR absorption at 1450 cm Ϫ1 , 1625-1712 cm Ϫ1 and 3426 cm Ϫ1 suggested the presence of phenyl, carbonyl and hydroxy groups in the structure. These data were similar to those of 2 and 3, 15, 16) suggesting that 1 also has a common isochromane-like ring with a similar hydrophobic side chain.
Structure Elucidation The molecular formula of 1 was determined to be C 22 H 20 O 8 on the basis of HR-FAB-MS measurement. The 13 C-NMR spectrum (in DMSO-d 6 ) showed 22 resolved signals, which were classified into three methyl carbons, one oxygenated methyl carbon, one oxy- 6 ) displayed 20 proton signals, six of which were suggested to be two hydroxy protons (d 7.98, 9.67) and one aromatic oxygenated methyl proton (d 3.60). These results supported the molecular formula. The connectivity of proton and carbon atoms was established by the 13 C-1 H HSQC spectrum ( Table 2) . Analyses of 1 H-1 H correlation spectroscopy (COSY) revealed the presence of one partial structure I, as shown in Fig. 2a . Furthermore, 13 H HMBC experiments. Taken together, the structure of 1 was elucidated as shown in Fig. 1 . The structure satisfied the degree of unsaturation and the molecular formula. All spectral data were reasonable when compared with those of 2 15) and 3 16) (Fig. 1) 
16)
Biological Properties Compound 2 was reported as a geranylgeranyltransferase I (GGTase I) inhibitor, 15) while the biological activity of 3 has not been reported. In this study, they were found to have miconazole-potentiating activity against C. albicans. Namely, 1 to 3 showed no inhibition zone against C. albicans even at 50 mg/6 mm disk on Plate A (GY agar); however, these compounds gave dose-dependent inhibition zones on Plate B (Plate A containing 0.060 mM miconazole) (Table 3 ). These results indicated that 1 to 3 potentiate miconazole activity against C. albicans. GGTase I was reported to be responsible for cell wall biosynthesis of C. albicans. 15) Therefore, it might be that mitorubrins inhibit GGTase I to potentiate miconazole activity, but it remains to be defined. Regarding antimicrobial activity against other microorganisms, as described in Experimental, these compounds showed very weak antibacterial activity only against X. camperstris with the same size (7 mm) of inhibition zone at 10 mg/6 mm disk, but no activity against the other five microorganisms. 
